ghk cu loose skin Advice on Ghk-Cu protocol/ : r/Peptides 000 mg helps support hydrated GHK-Cu Skin Smoothing and Soothing
Description
Not in a phase 1 safety trial

It has not progressed to extensive clinical trials, meaning its human safety and efficacy profile is not established it remains strictly a preclinical research compound

The first step is to measure cardiovascular risk more accurately, think in cumulative exposure rather than only 10-year horizons, use apoB where possible and especially where standard markers are most likely to underrepresent risk, intervene earlier when trajectory, family history, metabolic phenotype, or imaging suggest that the risk is being understated, and keep treatment burden proportional to the quality of evidence and the person in front of the doctor

Mass spectrometry data confirming molecular weight

For some, this can be a more comfortable option with less potential for soreness at the injection site
